Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 18, 2009
Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathwaysJosef Wanninger, Markus Neumeier, Johanna Weigert, et al.
The Journal of Clinical Endocrinology and Metabolism|January 19, 2010
Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetesJohanna Weigert, Markus Neumeier, Josef Wanninger, et al.
Cytokine|July 20, 2010
Impaired hepatic removal of interleukin-6 in patients with liver cirrhosisReiner Wiest, Johanna Weigert, Josef Wanninger, et al.
World Journal of Gastroenterology|September 29, 2006
Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosisMarkus Neumeier, Claus Hellerbrand, Erwin Gäbele, et al.
Experimental & Molecular Medicine|March 27, 2009
Annexin A6 is highly abundant in monocytes of obese and type 2 diabetic individuals and is downregulated by adiponectin in vitroFabian Stogbauer, Johanna Weigert, Markus Neumeier, et al.
Inflammatory Bowel Diseases|August 29, 2009
Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's diseaseJohanna Weigert, Florian Obermeier, Markus Neumeier, et al.
Clinical Endocrinology|June 30, 2009
Systemic chemerin is related to inflammation rather than obesity in type 2 diabetesJohanna Weigert, Markus Neumeier, Josef Wanninger, et al.
FEBS Letters|August 2, 2008
Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin releaseJohanna Weigert, Markus Neumeier, Sabrina Bauer, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 12, 2007
Detection of adiponectin in cerebrospinal fluid in humansMarkus Neumeier, Johanna Weigert, Roland Buettner, et al.
Cytokine|January 9, 2009
Adiponectin upregulates monocytic activin A but systemic levels are not altered in obesity or type 2 diabetesJohanna Weigert, Markus Neumeier, Josef Wanninger, et al.
Pageof 4